Research ArticleNew Research, Disorders of the Nervous System

Longitudinal Effects of Ketamine on Dendritic Architecture In Vivo in the Mouse Medial Frontal Cortex

Victoria Phoumthipphavong, Florent Barthas, Samantha Hassett and Alex C. Kwan
eNeuro 23 March 2016, 3 (2) ENEURO.0133-15.2016; https://doi.org/10.1523/ENEURO.0133-15.2016

Abstract

A single subanesthetic dose of ketamine, an NMDA receptor antagonist, leads to fast-acting antidepressant effects. In rodent models, systemic ketamine is associated with higher dendritic spine density in the prefrontal cortex, reflecting structural remodeling that may underlie the behavioral changes. However, turnover of dendritic spines is a dynamic process in vivo, and the longitudinal effects of ketamine on structural plasticity remain unclear. The purpose of the current study is to use subcellular resolution optical imaging to determine the time course of dendritic alterations in vivo following systemic ketamine administration in mice. We used two-photon microscopy to visualize repeatedly the same set of dendritic branches in the mouse medial frontal cortex (MFC) before and after a single injection of ketamine or saline. Compared to controls, ketamine-injected mice had higher dendritic spine density in MFC for up to 2 weeks. This prolonged increase in spine density was driven by an elevated spine formation rate, and not by changes in the spine elimination rate. A fraction of the new spines following ketamine injection was persistent, which is indicative of functional synapses. In a few cases, we also observed retraction of distal apical tuft branches on the day immediately after ketamine administration. These results indicate that following systemic ketamine administration, certain dendritic inputs in MFC are removed immediately, while others are added gradually. These dynamic structural modifications are consistent with a model of ketamine action in which the net effect is a rebalancing of synaptic inputs received by frontal cortical neurons.

Significance Statement

A single dose of ketamine leads to fast-acting antidepressant effects, and thus understanding its mechanism of action would facilitate the development of new treatments for mood disorders. One potential mechanism is the remodeling of synaptic connections, because ketamine administration in rodents leads to a higher density of dendritic spines in the frontal cortex. Structural remodeling, however, is a dynamic process, and the longitudinal effects of ketamine are poorly understood. In this study, we used subcellular resolution optical imaging methods to repeatedly visualize dendritic spines from the same set of neurons for >2 weeks in the mouse frontal cortex. The results are consistent with a model of action for ketamine involving the rebalancing of synaptic inputs in the frontal cortex.

Introduction

Major depressive disorder is a top contributor to disease burden among mental illnesses in the United States (Murray et al., 2013). Core symptoms for depressive disorders are debilitating, yet treatment options are limited. Typical antidepressants require several weeks to months to be effective, and approximately one-third of patients remain nonresponsive even after multiple trials. In contrast to the slow onset of action for the currently available antidepressants, a single dose of ketamine produces antidepressant effects within several hours (Berman et al., 2000) and can last for up to 2 weeks (Ibrahim et al., 2012). Studies of ketamine effects in animal models have found antidepressant-like behavioral responses in naive and stressed rodents (Li et al., 2010; Autry et al., 2011; Li et al., 2011; Donahue et al., 2014). These studies have shed light on the molecular signaling pathways recruited by systemic ketamine administration. However, still unclear are the cellular and network mechanisms responsible for the behavioral improvements (Sanacora and Schatzberg, 2015).

One striking consequence of systemic ketamine administration in naive rodents is an increase in the dendritic spine density in the distal and proximal tufts of layer 5 pyramidal neurons in the medial prefrontal cortex (Li et al., 2010; Liu et al., 2013; Ruddy et al., 2015). These observations of synaptogenesis are in stark contrast with the structural and synaptic atrophy reported for patients with major depression (Drevets et al., 1997; Kang et al., 2012) and in chronic stress models (Cook and Wellman, 2004; Radley et al., 2004; Liston et al., 2006; Christoffel et al., 2011). The opposing effects of ketamine and stress on neural architecture suggest that there could be a structural basis for antidepressant actions. Namely, fast-acting antidepressants such as ketamine may restore synaptic connections that were lost in stress and mood disorders (Duman and Aghajanian, 2012). Indeed, when chronically stressed rats were injected with a single dose of ketamine, the stress-induced reduction in dendritic spine density could be reversed (Li et al., 2011).

However, the turnover of dendritic spines is a dynamic process in vivo. An increase in dendritic spine density could be due to an increase in formation rate, a decrease in elimination rate, or a combination of both factors. Moreover, newly formed spines can be transient or persistent, either disappearing or stabilizing after several days. It is unknown whether new spines following systemic ketamine are persistent and thus are associated with functional synapses (Knott et al., 2006). Characterizing these dynamics requires longitudinal methods. Two-photon microscopy is an optical imaging technique that enables the visualization of dendritic architecture in vivo at subcellular resolution for up to several months (Grutzendler et al., 2002; Holtmaat et al., 2009). This approach has been used to investigate structural plasticity following sensory experience (Trachtenberg et al., 2002), learning (Fu et al., 2012; Lai et al., 2013), and exposure to substances, including corticosterone (Liston and Gan, 2011) and cocaine (Muñoz-Cuevas et al., 2013).

In this study, we used two-photon imaging to characterize the effects of a single subanesthetic dose of ketamine on the dendritic architecture in the mouse medial frontal cortex (MFC). Our results showed that systemic ketamine leads to a relative increase in dendritic spine density, a prolonged change driven by an elevated rate of spine formation. A fraction of the ketamine-induced new spines was persistent and could be observed after 4 d, which is indicative of functional synapses. Unexpectedly, we also observed a loss of distal apical tuft branches that occurred specifically and immediately on the day after ketamine administration. These data demonstrate distinct short- and long-term consequences of ketamine on dendritic architecture, and highlight its impact on modifying the synaptic inputs impinging on frontal cortical neurons.

Materials and Methods

Mice

All animal procedures were performed in accordance with the regulations of the Yale University animal care committee. Experiments were performed on adult (postnatal day 73–149) Thy1-GFP-M (n = 13; #007788, The Jackson Laboratory, RRID:IMSR_JAX:007788) and Thy1-YFP-H transgenic mice (n = 3; #003782, The Jackson Laboratory, RRID:IMSR_JAX:003782). Mice of both sexes were used. Mice were housed under controlled temperature on a 12 h light/dark cycle with siblings (one to five per cage) and nesting material.

Surgery

Anesthesia was induced with a 2% isoflurane and oxygen mixture, which was lowered to 1.5% for the remainder of the surgery. Mice were secured by ear bars in a stereotaxic frame. Their body temperature was regulated with a hot water circulation pad. Mice were injected with carprofen (5 mg/kg, s.c.; catalog #024751, Butler Schein Animal Health) and dexamethasone (40 mg/kg, i.m.; catalog #D4902, Sigma-Aldrich) prior to surgery. A 2- to 3-mm-diameter craniotomy was made over the right medial frontal cortex (AP = 1.5 mm, ML = 0.5 mm) with a handheld dental drill. After the skull was carefully removed, the surface of the brain was irrigated with an artificial cerebrospinal fluid (ACSF; in mm: 5 KCl, 5 HEPES, 135 NaCl, 1 MgCl2, and 1.8 CaCl2, pH 7.3) until bleeding subsides. A drop of warmed, low-melting point agarose solution (2% in ACSF; Type III-A, High EEO agarose, catalog #A9793, Sigma-Aldrich) was applied over the craniotomy. A two-layer glass plug was fabricated by first etching out a 2-mm-diameter circle from a #0 thickness glass coverslip, then bonded with UV-activated epoxy (NT37-322, Edmund Optics) to a #1 thickness, 3-mm-diameter round glass coverslip (catalog #64-0720-CS-3R, Warner Instruments). The glass plug was placed over the craniotomy and held in place until the agarose solidifies. The glass plug was then stabilized by applying light pressure and adding superglue around the edges. A stainless steel head plate was affixed to the skull using C&B-METABOND (Parkell Inc.). Mice were given another dose of carprofen (5 mg/kg, s.c.) immediately after surgery and for each of the following 3 d (5 mg/kg, i.p.). Mice were given a period of at least 3 weeks to recover before imaging begins.

Imaging

Mice were anesthetized with 1.5% isoflurane and head fixed. Temperature was regulated using a heating pad with rectal probe feedback. The two-photon microscope (Movable Objective Microscope, Sutter Instrument) was controlled using the ScanImage software (Pologruto et al., 2003, RRID:SCR_014307). Excitation was provided by an ultrafast laser (Chameleon Ultra II, Coherent) and focused with a high-numerical aperture microscope objective (XLUMPLFLN20X/1.0, Olympus). For imaging green fluorescent protein (GFP)- or yellow fluorescent protein (YFP)-expressing dendrites, excitation wavelength was set at 920 nm, and emission was collected behind a bandpass filter from 475 to 550 nm. Each mouse was injected with either ketamine (10 mg/kg, i.p.) or saline vehicle on a non-imaging day. To investigate short-term effects, mice were imaged on days −3, −1, and 1 relative to the day of injection. For long-term studies, mice were imaged on days −3, −1, 1, 3, 5, 10, and 15 relative to the day of injection. Multiple fields of view were imaged in the same mouse. The same field of view was identified across days by finding landmark structures such as blood vessels or an edge of the glass window. At each field of view, image stacks were acquired at 1024 × 1024 pixels, spanning a field of view of 60.5 × 60.5 μm, and at 2 μm steps for a z-range of 20–30 μm. Each imaging session lasted up to 2.5 h. Although we did not explicitly record the duration of imaging sessions, we estimated post hoc based on the acquisition times of the first and last image files in the computer.

Image analysis

In all of the figures, we are presenting the raw images with only adjustments to the black-and-white levels (linear), with no modification to contrast (nonlinear) or removal of neighboring axons, or any other manipulations. Initially, image stacks were processed for motion correction using the StackReg plug-in (Thévenaz et al., 1998, RRID:SCR_014308) in ImageJ (Schneider et al., 2012, RRID:SCR_003070). Then, structural parameters were analyzed from each image stack using ImageJ. The physical parameters of dendritic spines were characterized based on criteria established in a standardized protocol (Holtmaat et al., 2009). Briefly, dendritic spines were counted if the protrusions extended at least 0.4 μm away from the shaft. Dendritic spine length was the distance from the base at the shaft to the tip. Dendritic spine head diameter was the width at the widest extent of the spine. Distances were measured using the line segment tool in ImageJ. The dendritic spine formation rate was defined as the number of new spine protrusions observed in two consecutive imaging sessions divided by the total number of dendritic spines in the first imaging session. To assess longitudinal changes in the spine formation rate, we calculated the difference from baseline by subtracting the formation rate of each field of view by the baseline rate of the subject. The baseline rate of each subject was estimated by averaging the spine formation rates of all fields of view imaged from the same individual prior to injection (i.e. between days −3 and −1). The dendritic elimination rate was quantified using the same procedure for spine protrusions that disappeared. Most of the sessions were imaged 2 d apart, but some sessions were imaged 5 d apart (i.e., days 5–10 and days 10–15). Presumably, with the same spine formation rate, we would observe more new spines in sessions occurring 5 d apart relative to those occurring 2 d apart because more time has elapsed. Therefore, when estimating the spine formation/elimination rate from new/lost spine counts, we report turnover rates for sessions occurring 5 d apart with a correction factor, by multiplying the measured rates by two-fifths. For the apical tuft branches, dendritic segments were traced over using the freehand line tool, and then summed for total length in ImageJ. To assess longitudinal changes of the imaged dendritic segments, we calculated the fold change from the last session for each field of view by dividing the measured branch length of an imaging session by that of the prior imaging session.

Statistics

We performed statistical tests considering fields of view as independent samples. This is a major assumption, justified in part by the fact that the fields of view were at random, nonoverlapping locations and that each one comprises a very small portion (0.06%) of the window area of each mouse. The reason for making this assumption is that a different number of fields of view was obtained for each mouse, so if we compare subjects only, the results will have a bias for those with fewer fields of view. To ensure that this assumption does not affect the major conclusions of the study, we repeated statistical tests in data from three sessions considering each mouse as a sample when possible. For all longitudinal results, two-way mixed ANOVA with repeated measures was used to test the factors contributing to changes in spine density, dendritic branch length, spine formation rate, and spine elimination rate. The factors were treatment (with ketamine or saline; between-subject), day (within-subject), and their interaction. The two-tailed t test was used to compare means that did not involve multiple days. The two-sample Kolmogorov–Smirnov test was used to compare cumulative distributions. Data are reported as the mean ± SEM. Table 1 contains a list of the statistical tests performed, p values, and sample sizes. p values and sample sizes are reported instead of observed power to provide more information on the samples involved and because the p values are directly related to the observed power.

View this table:
Table 1:

Statistical table

Results

Longitudinal imaging of dendritic architecture in the mouse medial frontal cortex in vivo

To visualize dendritic architecture, we performed two-photon microscopy (Fig. 1A,B) using the transgenic Thy1-GFP-M and Thy1-YFP-H mice (Feng et al., 2000), in which a sparse subset of neocortical neurons expresses the enhanced GFP or YFP. Many studies have used these mouse lines to investigate structural remodeling, but primarily in the sensory cortices (Trachtenberg et al., 2002; Knott et al., 2006). Therefore, we started by examining the distribution of fluorescent neurons in the frontal cortex. Fluorescence imaging of fixed coronal sections confirmed sparse labeling in anterior cingulate cortex (Cg1) and secondary motor cortex (M2; Fig. 1C). In these regions, fluorescence signals originated predominantly from layer 5 pyramidal neurons, as is evident from the laminar position of the cell bodies. This is consistent with the knowledge that only deep-layer pyramidal neurons are labeled in these two mouse lines (Feng et al., 2000). Interestingly, although there were no fluorescent cell bodies in the superficial layers, a band of the fluorescence signal could be seen in layer 2/3, particularly in the medial regions. This band may arise from axons in other brain regions, such as basolateral amygdala, that send long-range projections to frontal cortical regions (Oh et al., 2014).

Figure 1.
Figure 1.

Longitudinal imaging of dendritic architecture in the mouse medial frontal cortex. A, Schematic of the imaging experiment. B, Schematic of the long-term window implant. C, Fluorescence image of a fixed coronal brain slice from a Thy1-GFP-M mouse following longitudinal imaging. Cg1 and M2 (i.e., the MFC) were imaged in this study. PrL, prelimbic cortex. M1, primary motor cortex. D, Bright-field image of the long-term window implant. The glass window has an ∼2-mm-diameter width (circle), which is much larger than the imaging field of view of ∼60 × 60 μm (filled square). E, A low-magnification, in vivo two-photon image from layer 1 of the MFC in a Thy1-GFP-M mouse. Distal apical tuft branches from GFP-expressing layer 5 pyramidal neurons were visible. F, A high-magnification image of a region in E.

In this study, we imaged layer 1 of the MFC, which includes Cg1 and M2. The choice of MFC was due to practical reasons because two-photon microscopy has depth limitations. Nevertheless, MFC is appropriate for studies of antidepressants as numerous studies have reported stress-induced structural and functional alterations in rodents, either specifically in the cingulate region (Liston et al., 2006; Ito et al., 2010; Kassem et al., 2013) or in a greater region that includes MFC (Radley et al., 2004; 2006; Cerqueira et al., 2007). These results are consistent with a recent brain-wide mapping study, which identified both Cg1 and M2 as regions with significantly reduced activity levels in a learned helplessness model of depression (Kim et al., 2016). Moreover, mapping of metabolic activity after systemic ketamine showed that MFC is among the activated brain regions in rodents (Duncan et al., 1999; Miyamoto et al., 2000). To prepare for longitudinal in vivo imaging, we performed a craniotomy above MFC and implanted a long-term ∼2-mm-diameter glass window (Fig. 1D). After recovery, mice were anesthetized with isoflurane and affixed on head posts under a two-photon microscope. Figure 1E shows a low-magnification image of the GFP-expressing dendrites in MFC in vivo. For counting dendritic spines, we acquired high-magnification 20- to 30-μm-thick image stacks at multiple fields of view (Fig. 1F). Individual dendritic branches could be distinguished from axons by the protruding dendritic spines along the segments. Because we were imaging superficial layers, these neuronal processes represented the distal apical tuft branches of layer 5 pyramidal neurons. We note that all images presented in this article have only linear adjustments to black-and-white levels, but have not otherwise been altered (see Materials and Methods).

Systemic ketamine administration is associated with higher dendritic spine density in MFC for 2 weeks

To examine the effects of ketamine on structural plasticity in the MFC, we visualized the same fields of view on multiple imaging sessions in adult mice, while administering either a single subanesthetic dose of ketamine (10 mg/kg, i.p.) or saline vehicle (Fig. 2A). We imaged on days −3, −1, 1, 3, 5, 10, and 15 from the injection day. We did not image on the injection day because anesthesia would interfere with neural activity, which is required for the antidepressant effects of ketamine (Fuchikami et al., 2015). We focused on the medial half of the 2-mm-diameter glass window. Image stacks were acquired from multiple, nonoverlapping fields of view (60.5 × 60.5 μm), each representing a tiny portion of the window area (0.06%; Fig. 1D). In total, we tracked 1,665 spines for ketamine (n = 8 mice; 58 fields of view, range 4–21 per mouse) and 3,814 spines for saline (n = 8 mice; 97 fields of view, range 4–17 per mouse). All the experiments involved at least the first three sessions. In a subset of experiments, we tracked dendritic architecture for the full seven-session period, including 800 spines for ketamine (n = 3 mice; 28 fields of view) and 783 spines for saline (n = 2 mice; 25 fields of view). For each field of view, we counted multiple branches including dozens of dendritic spines (mean = 38 spines/field of view, SD = 17). In the first imaging session, we measured the mean baseline dendritic spine density in MFC to be 0.28 spines/μm (SD = 0.08; n = 155 fields of view). This value for dendritic spine density is ∼25% lower than a previous measurement from the mouse dorsomedial prefrontal cortex (Muñoz-Cuevas et al., 2013), a difference that may be attributed to our mice being older adults.

Figure 2.
Figure 2.

Systemic ketamine administration leads to higher dendritic spine density for at least 2 weeks relative to that of controls. A, Time line of the experiment. Ketamine was administered at a dose of 10 mg/kg through intraperitoneal injection. B, An example imaging field of view acquired on day −3 in a Thy1-GFP-M mouse. Yellow boxes indicate the dendritic branches shown as examples in C and D. C, Images of an apical dendritic tuft branch at days −1 and 10 from ketamine administration in a Thy1-GFP-M mouse. In the bottom right, axonal processes and boutons are visible. Green arrowhead, stable spine. D, Another apical dendritic tuft branch from the same field of view at days −3, −1, 1, 3, 10, and 15 from ketamine administration in a Thy1-GFP-M mouse. A new spine (yellow arrowhead) appeared on day 10 next to a stable spine (green arrowhead). E, Change in dendritic spine density across days, expressed as a fold change from the value measured on the first imaging session. The mouse was injected with either ketamine (blue square) or saline (black circle). Values are reported as the mean ± SEM. N = 28 and 25 fields of view across 7 sessions for ketamine- and saline-injected mice.

Comparing the pre-ketamine administration and post-ketamine administration sessions, most dendritic spines were stable (Fig. 2C,D, green arrowheads). However, there were also instances where new spines were found (Fig. 2D, yellow arrowhead). To summarize data for ketamine and saline conditions, we quantified the fold change in dendritic spine density from baseline (day −3 from injection) for each field of view. Systemic ketamine was associated with higher dendritic spine density in the MFC (treatment: p = 6 × 10−7, F(1,276) = 26.0; day: p = 0.40, F(5,276) = 1.03; interaction: p = 0.39, F(5,276) = 1.05; two-way ANOVA; Fig. 2E) relative to the saline group. It is noteworthy that we also observed a decline in dendritic spine density across days for saline-injected subjects (Fig. 2E, black line). This reduction of spine density in the “control” condition may be due to a number of factors, which will be discussed in a later section.

Higher dendritic spine density is driven by an elevated rate of spine formation

Next we wanted to find the changes in dendritic spine turnover dynamics responsible for the relative increase in dendritic spine density. Because the largest spine density increase was found on the day after ketamine injection, we focused the analysis on the entire dataset across a period including days −3, 1, and 1 (Fig. 3A). Figure 3B shows two image montages of apical tuft branches before and after ketamine injection. To quantify spine turnover dynamics, we compared the same fields of view across consecutive imaging sessions to count the number of new and eliminated spines. Relative to the preinjection baseline, we found an increase in spine formation rate following systemic ketamine injection that was different from that found in the saline group (treatment: p = 0.03, F(1,287) = 4.61; day: p = 0.001, F(1,287) = 10.3; interaction: p = 0.03, F(1,287) = 4.61; two-way ANOVA; Fig. 3C). In contrast, although there were changes in spine elimination rates across days, there was no difference between mice that received ketamine or saline (treatment: p = 0.9, F(1,286) = 0.02; day: p = 0.003, F(1,286) = 9.09; interaction: p = 0.9, F(1,286) = 0.02; two-way ANOVA; Fig. 3D). We also plotted the spine turnover rates using only the seven-session dataset for the ketamine (Fig. 3E) and saline groups (Fig. 3F). Ketamine remained a significant factor contributing to a difference in spine formation rate (treatment: p = 2 × 10−4, F(1,267) = 14.5; day: p = 0.5, F(5,267) = 0.89; interaction: p = 0.08, F(5,267) = 1.96; two-way ANOVA), but not in the spine elimination rate (treatment: p = 0.1, F(1,267) = 2.79; day: p = 0.001, F(5,267) = 4.19; interaction: p = 0.07, F(5,267) = 2.03; two-way ANOVA). These results indicate that an elevated rate of spine formation is the driving force behind the higher spine density in the MFC following ketamine administration.

Figure 3.
Figure 3.

Higher spine density is due to an elevated rate of spine formation. A, Time line of the experiment. Ketamine was administered at a dose of 10 mg/kg through intraperitoneal injection. B, Images of two different apical dendritic tuft branches at days −3, −1, and 1 from ketamine administration in a Thy1-GFP-M mouse. Yellow arrowhead, new spine. C, Change in spine formation rate, expressed as the difference from the value measured between days −3 and −1 (i.e., preinjection sessions). The mouse was injected with either ketamine (blue square) or saline (black circle). Values are reported as the mean ± SEM. N = 58 and 97 fields of view across three sessions for ketamine- and saline-injected mice. D, Same as C for spine elimination rate. E, Change in spine turnover dynamics across days for mice injected with ketamine. Solid square, spine formation rate. Open square, spine elimination rate. Values are reported as the mean ± SEM. F, Same as E for controls with saline injection. N = 28 and 25 fields of view across seven sessions for ketamine- and saline-injected mice. G, A histogram of the change in dendritic spine density, expressed as the fold change from day −3 to day 1 from injection. Top, saline. Bottom, ketamine. N = 58 and 97 fields of view for ketamine- and saline-injected mice.

Although the mean spine formation rate was higher for mice with systemic ketamine administration relative to saline administration, there was variability across fields of view (Fig. 3G). As described previously, there was a decline in spine density across days in saline-injected subjects, and accordingly 83% of the imaged field of dendritic tuft branches had reduced spine density compared with the first-day baseline. By contrast, about half of the fields of view had an increase in spine density following ketamine injection (40%; p = 0.005, χ2 = 7.8, χ2 test). Using fields of view allows us to examine more finely the variability in the data; however, the results could be correlated among fields of view from the same individual. Therefore, we verified, on a per-subject basis across 7 d, that there is a significant effect of treatment on dendritic spine density (treatment: p = 0.007, F(1,16) = 9.39; day: p = 0.87, F(5,16) = 0.35; interaction: p = 0.46, F(5,16) = 0.98; two-way ANOVA), that there is an effect that was near to but did not reach statistical significance for the effect of treatment on spine formation rate (treatment: p = 0.07, F(1,16) = 3.87; day: p = 0.96, F(5,16) = 0.20; interaction: p = 0.69, F(5,16) = 0.62; two-way ANOVA), and that there is no effect of treatment on spine elimination rate (treatment: p = 0.64, F(1,16) = 0.23; day: p = 0.23, F(5,16) = 1.56; interaction: p = 0.62, F(5,16) = 0.71; two-way ANOVA).

A fraction of the newly formed spines associated with ketamine administration is persistent

An important question is whether the new dendritic spines associated with ketamine administration become functional synapses. A previous study (Knott et al., 2006) correlated images from two-photon and electron microscopy to show that a fraction of the newly formed dendritic spines is transient and disappears, whereas persistent spines that are stable for >4 d had synapses. For the new spines that were observed on the day following ketamine or saline injection, we quantified the fraction that could be observed at the same location 4 d later. Across fields of view, we found no difference in the fraction of spines that became persistent for ketamine versus that for saline (mean ± SEM: ketamine, 39 ± 5%; saline, 32 ± 4%; p = 0.3, t(40) = 0.99, unpaired t test; Fig. 4A). However, the persistent fraction decreased over longer periods for ketamine-injected mice (day 5 vs day 10: p = 0.007, t(17) = 3.08; day 5 vs day 15: p = 0.002, t(15) = 3.85; paired t test, exact p values were reported without multiple-comparison adjustment), whereas it was unchanged for saline-injected mice (day 5 vs day 10: p = 0.1, t(19) = 1.74; day 5 vs day 15: p = 0.9, t(12) = −0.17; paired t test, exact p values were reported without multiple-comparison adjustment).

Figure 4.
Figure 4.

Newly formed protrusions following systemic ketamine administration are consistent with nascent spines. A, The fraction of newly formed spines found on day 1 that could be observed again on day 5, 10, or 15 for mice injected with saline (black) or ketamine (blue). Paired t test for comparisons across days in the same condition. Unpaired t test for the comparison across conditions. The p values are shown as is without multiple-comparison correction. Values are reported as the mean ± SEM. N = 28 and 25 fields of view for ketamine- and saline-injected mice. B, Distribution of spine protrusion lengths, comparing newly formed spines and existing stable spines that were on the same dendritic branch. Measurements were taken either before ketamine administration, on day −1, or after ketamine administration, on day 1, 3, 5, 10, or 15. ***, p < 0.001, two-sample Kolmogorov–Smirnov test. N = 61 new spines and 61 matched existing neighboring spines measured before ketamine administration. N = 328 new spines and 328 matched existing neighboring spines measured after ketamine administration. C, Same as B for spine head widths.

Furthermore, larger spines are known to correlate with more mature and stronger synaptic connections (Kasai et al., 2003). We measured the length and width of spine heads, comparing between newly formed spines, and matched each of those with a neighboring stable spine on the same dendritic branch. Relative to existing spines, new spines that appeared immediately on the day following systemic ketamine were shorter (mean ± SEM: new, 1.25 ± 0.04 μm, n = 328; existing, 1.35 ± 0.03 μm, n = 328; p = 0.02, t(327) = −2.39, paired t test) and narrower (mean ± SEM: new, 0.74 ± 0.01 μm; existing, 0.83 ± 0.02 μm; p = 3 × 10−5, t(327) = −4.19, paired t test). These differences in averages were reflected as differences in the cumulative distributions as well (spine length: p = 9 × 10−6, D(328,328) = 0.19; spine width: p = 4 × 10−4, D(328,328) = 0.16; two-sample Kolmogorov–Smirnov test; Fig. 4B,C). However, when we compared pre-ketamine administration with post-ketamine administration conditions, we did not find any difference in dendritic spine morphology (spine length, new spines: p = 0.9, D(61,328) = 0.08; spine length, existing spines: p = 0.09, D(61,328) = 0.17; spine width, new spines: p = 0.2, D(61,328) = 0.15; spine width, existing spines: p = 0.5, D(61,328) = 0.12; two-sample Kolmogorov–Smirnov test). The distributions of spine protrusion length and spine head width did not suggest obvious ways to segment the data, and therefore we did not attempt to identify types (i.e., stubby, mushroom like, or filopodia like). Together, these results indicate that newly formed protrusions following systemic ketamine administration have similar morphological characteristics to those that occurred before systemic ketamine administration. The new spine heads are shorter and narrower, which is broadly consistent with nascent spines that precede synapse formation. Nevertheless, a fraction of these spines that formed after systemic ketamine administration becomes persistent and likely reflects new synaptic connections.

Ketamine also leads to rapid retraction of distal apical tuft branches

Unexpectedly, we also observed alterations to the distal apical tuft branches following ketamine injection in a fraction (18%) of the fields of view (Fig. 5A). Figure 5B shows the same field of view across imaging sessions where a distal branch segment was visible in a preinjection session (Fig. 5B, red arrowheads), and then disappeared on the day following systemic ketamine administration. This observation was not due to out of focus imaging, because we acquired volumetric image stacks where neuronal processes below and above the image plane were clearly visible and stable (Fig. 5B, green arrowheads). No additional alterations were observed in the subsequent days (Fig. 5C). Analysis of the longitudinal dataset revealed a mean change of −10 ± 3% in the total length of the imaged apical tuft branches on day 1 after ketamine injection (treatment: p = 1 × 10−12, F(1,236) = 56.5; day: p = 0.02, F(5,236) = 2.77; interaction: p = 0.02, F(5,236) = 2.77; two-way ANOVA; Fig. 5D). We compared fields of view with and without apical tuft branch loss and found no differences in their spine turnover rates (p = 0.2, formation; p = 0.3 elimination; unpaired t test). We also asked whether stable and retracted dendritic branches had different widths, but did not find any difference (p = 0.4, t(131) = −0.77, unpaired t test; Fig. 5E). Additional statistical tests on a per-subject basis for the three-session data confirmed a significant effect of treatment on apical tuft branch length (treatment: p = 0.003, F(1,16) = 12.08; day: p = 0.7, F(5,16) = 0.62; interaction: p = 0.7, F(5,16) = 0.62; two-way ANOVA). These results show that systemic ketamine has a short-term effect of removing a small portion of the apical dendritic tuft branches in layer 1.

Figure 5.
Figure 5.

Systemic ketamine administration associated with the retraction of distal apical tuft branches. A, Time line of the experiment. Ketamine was administered at a dose of 10 mg/kg through intraperitoneal injection. B, Images from multiple z-depths of a volumetric acquisition of dendritic architecture obtained in a Thy1-GFP-M mouse before and after ketamine administration. Note that, although most branch segments were stable (green arrowhead), a segment in the middle of the volume has retracted (red arrowhead). C, Same field of view as B at days 3, 10, and 15 from ketamine administration. D, Change in distal apical tuft branch length in layer 1 across days, with the fold change calculated by dividing the length of each session by that from the prior session. The mouse was injected with either ketamine (blue square) or saline vehicle (black circles). Values are reported as the mean ± SEM. N = 28 and 25 fields of view across seven sessions for ketamine- and saline-injected mice. E, Distributions of dendritic branch widths measured on day −1, plotted separately for those distal apical tuft branches that were stable (black) or retracted (red) on day 1. N = 117 stable and 16 retracted dendritic segments from ketamine-injected mice.

Potential factors contributing to the decline of dendritic spine density prior to injection

We observed a decline in dendritic spine density in saline-injected mice. To further investigate the potential contributing factors, we examined changes in spine density during the preinjection period, between days −3 and −1. There were no significant differences between mice to be injected with saline versus those to be injected with ketamine (p = 1, Wilcoxon rank-sum test; Fig. 6A), or between male and female subjects (p = 0.3, Wilcoxon rank-sum test; Fig. 6B). We conjecture that stress could arise from the duration of anesthesia required for imaging, but found no systematic trend between imaging session duration and changes in spine density (p = 0.8; t(13) = 0.26, linear regression, excluding an outlier at −0.3; Fig. 6C). There was also no significant trend for the age of the animal at the time of glass window implantation (p = 0.8; t(13) = −0.23, linear regression, excluding outlier at −0.3; Fig. 6D). A potential contributor is the age of the animal at the time of imaging, where older adults tended to have larger declines in dendritic spine density (p = 0.16; t(13) = −1.50, linear regression, excluding an outlier at −0.3; Fig. 6E), although this effect did not reach significance. We should note that there have been a couple of other reports (Wellman, 2001; Muñoz-Cuevas et al., 2013) of structural loss in rodent prefrontal cortex in control or vehicle-injected animals. These earlier studies along with our own data highlight the difficulty in achieving true controls in studies of frontal cortex, where the brain region is known to be sensitive to aversive life events.

Figure 6.
Figure 6.

Potential factors contributing to the decline of dendritic spine density prior to injection. A, Fold change in dendritic spine density from day −3 to day −1 (preinjection) for mice to be injected with saline or ketamine. Circle, male. Cross, female. Filled triangle, mean ± SEM. B, Same as A for female vs male mice. C, Fold change in dendritic spine density from day −3 to day −1 (preinjection) plotted as a function of the duration of the imaging session on day −3. Circle, male. Cross, female. Line, linear fit excluding the outlier at −0.3. D, Same as C for age at the time of surgery. E, Same as C for age at the time of the first imaging session.

Discussion

Our time-lapse results demonstrated higher dendritic spine density for up to 2 weeks after a single dose of ketamine relative to saline. This is a consequence of an elevated rate of spine formation. We also observed a loss of distal apical tuft branches that was specific to the day following ketamine injection. The short- and long-term effects on apical tuft branches and dendritic spine density would have opposite effects on the overall number of synaptic connections. By removing certain inputs immediately and adding others gradually, we suggest that ketamine may act to reorganize the types of synaptic inputs received by pyramidal neurons in the MFC. Physiological evidence hinted at this possibility; in the frontal cortex, hypocretin-sensitive synaptic inputs, likely distinct from those that mediate serotonergic signaling, originate from the thalamus. Intriguingly, although ketamine restores the magnitude of these synaptic currents in stressed rats, they appear to reach different levels relative to baseline (Li et al., 2011). Further experiments are needed to confirm the identities of the added and lost synaptic connections following systemic ketamine administration.

Our study builds on previous studies (Li et al., 2010, 2011) of ketamine in naive rats and chronic stress models, which found an increase in dendritic spine density in the distal and proximal tufts of layer 5 pyramidal neurons. These studies examined structural changes in the anterior cingulate and prelimbic regions by filling cells in brain slices prepared 24 h after treatment. Here, investigating effects in vivo, we found a relative increase in spine density in the MFC, which is more dorsally located but still part of the rodent medial prefrontal cortical network (Van De Werd et al., 2010; Vogt and Paxinos, 2014). We should emphasize that the observed relative increase is a result of dendritic spine density remaining mostly stable for ketamine, but declining for saline-injected mice. The decline of spine density in the saline group suggests that mice might have been stressed inadvertently in our experiments, potentially as a function of age at the time of imaging. Interestingly, other studies have observed an increase in dendritic spine density following a single dose of another rapid-acting antidepressant, scopolamine (Voleti et al., 2013), and reversal of stress-induced atrophy by long-term administration of fluoxetine (Bessa et al., 2009). Therefore, our results and studies in the field (Bessa et al., 2009; Li et al., 2010, 2011; Voleti et al., 2013) support a structural basis for antidepressant actions that may generalize beyond specific frontal cortical regions or pharmacological agents.

A novel finding is that the higher dendritic spine density after systemic ketamine administration is due to an elevated spine formation rate, but not to changes in the spine elimination rate. This increase in spine formation rate was largest on the day after systemic ketamine administration. For the later imaging sessions, the spine formation rate remained above the baseline, preinjection levels. This time course of elevated spine formation rate may be compared with the time course of the antidepressant effects of systemic ketamine. In rats, depressive-like behaviors, as assayed by forced swim and sucrose preference tests, were reduced 1 week after the injection of ketamine (Autry et al., 2011; Li et al., 2011). In patients with major depressive disorder, the duration of the antidepressant effects of ketamine varies from 3 d to 2 weeks (Ibrahim et al., 2012). Therefore, the long-term effect on dendritic spine turnover may relate to the sustained antidepressant effects observed in rodents and humans. Furthermore, the observation of changes in the dynamics of the spine formation rate, but not in other structural plasticity parameters, suggests that antidepressant effects may rely on molecular pathways that promote synaptogenesis, rather than those related to spine growth or pruning.

Several factors may influence the rates of ketamine-induced structural remodeling. Sex is a contributing variable because estrogen is known to affect structural plasticity (Srivastava et al., 2008). In this study, sex differences were not tested explicitly, owing to the limited sample size. Two lines of evidence suggest that pooling the data from males and females should not affect the conclusions of this study. First, we repeated the analysis using data from the five ketamine-injected males only, and found similar trends for ketamine-induced changes, including a relative increase in dendritic spine density and an elevated spine formation rate, but no change in the spine elimination rate. Second, two recent studies (Carrier and Kabbaj, 2013; Franceschelli et al., 2015) reported that although female rats are more sensitive to the antidepressant-like effects of ketamine at low dose, behavioral outcomes are similar between males and females at higher doses. Here, we used a dose (10 mg/kg) at which these studies found comparable behavioral effects for the sexes. Another potential variable is the surgical method. One report (Xu et al., 2007) argued that open-skull craniotomy can alter dendritic spine turnover rates, although another study (Holtmaat et al., 2009) found negligible differences across surgical preparations. The same procedures were applied to the ketamine and saline groups in our study; therefore, the influence of surgical methods on the across-group differences should be minimal. Furthermore, ketamine is often used with xylazine as an anesthetic. There is evidence that an anesthetic dose of ketamine has transient effects on the dynamics of dendritic filopodia but no effect on dendritic spines in 1-month-old mice (Yang et al., 2011). It is unclear how this prior result compares with the current findings, because we used a subanesthetic dose.

A surprising observation was the retraction of distal apical tuft branches, specific to the day after systemic ketamine administration. We emphasize that the imaged branch segments reside in the superficial layers of the cortex, therefore representing the distal portion and only a tiny fraction of the entire dendritic tree of a neuron. The loss of apical tuft branch tips may be due to the retraction of dendritic branches or the death of the neurons from which these dendrites arise, possibilities that could not be distinguished from our data. Nevertheless, our result was unexpected because, although some cortical cell types such as GABAergic interneurons can undergo branch tip reorganization under certain conditions (Chen et al., 2011), the dendritic branches of pyramidal neurons are thought to be stable in the neocortex of adult mice (Grutzendler et al., 2002). Studies have shown that structural plasticity in MFC is important for cognitive behaviors such as consolidation of contextual memory (Vetere et al., 2011) and adaptive decision-making (Liston et al., 2006; Dias-Ferreira et al., 2009). Therefore, the loss of dendritic materials may contribute to cognitive impairments, which are known to affect long-term ketamine users (Morgan et al., 2009). At higher dosages, repeated ketamine use has been associated with a reduced volume of hippocampus and frontal lobe in humans (Liao et al., 2011) and rodents (Kassem et al., 2013; Schobel et al., 2013). One correlated functional imaging study (Kassem et al., 2013) showed that such gray matter reduction is primarily due to a loss of dendrites and their synapses. There are ongoing efforts in the field to develop compounds with ketamine-like antidepressant actions but without the psychotomimetic effects, and it would be interesting to test whether those drugs may promote structural plasticity but spare dendritic material loss.

The short- and long-term effects of distal tuft branch loss and elevated spine formation rate have opposing effects on the total number of dendritic spines in the MFC. Long-range inputs into the superficial layers of rodent MFC come from multiple sources, including mediodorsal and midline thalamic nuclei, basolateral amygdala, and other prefrontal cortical areas (Hoover and Vertes, 2007; Oh et al., 2014). Specific types of prefrontal cortical inputs and outputs may be more plastic and susceptible to stress or ketamine (Shansky et al., 2009; Liu et al., 2015). Therefore, approaches that can alter prefrontal cortical circuitry with pathway specificity may be effective treatment options for mood disorders and merit further study.

Acknowledgments

Acknowledgments. We thank Ronald Duman and George Aghajanian for helpful discussions, William Cafferty for providing mice for pilot experiments, and Jaime Grutzendler for mice and advice on the surgery.

Footnotes

  • ↵1 The authors declare no competing financial interests.

  • ↵3 This work was supported by a NARSAD Young Investigator Award (A.C.K.), and the Golden Rule Family Foundation (A.C.K.).

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

References

  1. ↵
    Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng P-F, Kavalali ET, Monteggia LM (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475:91–95. doi:10.1038/nature10130 pmid:21677641
    OpenUrlCrossRefPubMed
  2. ↵
    Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47:351–354. pmid:10686270
    OpenUrlCrossRefPubMed
  3. ↵
    Bessa JM, Ferreira D, Melo I, Marques F, Cerqueira JJ, Palha JA, Almeida OFX, Sousa N (2009) The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry 14:764–73–739. doi:10.1038/mp.2008.119 pmid:18982002
    OpenUrlCrossRefPubMed
  4. ↵
    Carrier N, Kabbaj M (2013) Sex differences in the antidepressant-like effects of ketamine. Neuropharmacology 70:27–34. doi:10.1016/j.neuropharm.2012.12.009 pmid:23337256
    OpenUrlCrossRefPubMed
  5. ↵
    Cerqueira JJ, Taipa R, Uylings HBM, Almeida OFX, Sousa N (2007) Specific configuration of dendritic degeneration in pyramidal neurons of the medial prefrontal cortex induced by differing corticosteroid regimens. Cereb Cortex 17:1998–2006. doi:10.1093/cercor/bhl108
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Chen JL, Lin WC, Cha JW, So PT, Kubota Y, Nedivi E (2011) Structural basis for the role of inhibition in facilitating adult brain plasticity. Nat Neurosci 14:587–594. doi:10.1038/nn.2799 pmid:21478885
    OpenUrlCrossRefPubMed
  7. ↵
    Christoffel DJ, Golden SA, Russo SJ (2011) Structural and synaptic plasticity in stress-related disorders. Rev Neurosci 22:535–549. doi:10.1515/RNS.2011.044 pmid:21967517
    OpenUrlCrossRefPubMed
  8. ↵
    Cook SC, Wellman CL (2004) Chronic stress alters dendritic morphology in rat medial prefrontal cortex. J Neurobiol 60:236–248. doi:10.1002/neu.20025 pmid:15266654
    OpenUrlCrossRefPubMed
  9. ↵
    Dias-Ferreira E, Sousa JC, Melo I, Morgado P, Mesquita AR, Cerqueira JJ, Costa RM, Sousa N (2009) Chronic stress causes frontostriatal reorganization and affects decision-making. Science 325:621–625. doi:10.1126/science.1171203 pmid:19644122
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Donahue RJ, Muschamp JW, Russo SJ, Nestler EJ, Carlezon WA (2014) Effects of striatal ΔFosB overexpression and ketamine on social defeat stress-induced anhedonia in mice. Biol Psychiatry 76:550–558. doi:10.1016/j.biopsych.2013.12.014 pmid:24495460
    OpenUrlCrossRefPubMed
  11. ↵
    Drevets WC, Price JL, Simpson JR, Todd RD, Reich T, Vannier M, Raichle ME (1997) Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386:824–827. doi:10.1038/386824a0 pmid:9126739
    OpenUrlCrossRefPubMed
  12. ↵
    Duman RS, Aghajanian GK (2012) Synaptic dysfunction in depression: potential therapeutic targets. Science 338:68–72. doi:10.1126/science.1222939 pmid:23042884
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Duncan GE, Miyamoto S, Leipzig JN, Lieberman JA (1999) Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine. Brain Res 843:171–183. pmid:10528123
    OpenUrlCrossRefPubMed
  14. ↵
    Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, Wallace M, Nerbonne JM, Lichtman JW, Sanes JR (2000) Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28:41–51. pmid:11086982
    OpenUrlCrossRefPubMed
  15. ↵
    Franceschelli A, Sens J, Herchick S, Thelen C, Pitychoutis PM (2015) Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and “depressed” mice exposed to chronic mild stress. Neuroscience 290:49–60. doi:10.1016/j.neuroscience.2015.01.008 pmid:25595985
    OpenUrlCrossRefPubMed
  16. ↵
    Fu M, Yu X, Lu J, Zuo Y (2012) Repetitive motor learning induces coordinated formation of clustered dendritic spines in vivo. Nature 483:92–95. doi:10.1038/nature10844 pmid:22343892
    OpenUrlCrossRefPubMed
  17. ↵
    Fuchikami M, Thomas A, Liu R, Wohleb ES, Land BB, DiLeone RJ, Aghajanian GK, Duman RS (2015) Optogenetic stimulation of infralimbic PFC reproduces ketamine's rapid and sustained antidepressant actions. Proc Natl Acad Sci U S A 112:8106–8111. doi:10.1073/pnas.1414728112 pmid:26056286
    OpenUrlAbstract/FREE Full Text
  18. ↵
    Grutzendler J, Kasthuri N, Gan W-B (2002) Long-term dendritic spine stability in the adult cortex. Nature 420:812–816. doi:10.1038/nature01276 pmid:12490949
    OpenUrlCrossRefPubMed
  19. ↵
    Holtmaat A, Bonhoeffer T, Chow DK, Chuckowree J, De Paola V, Hofer SB, Hübener M, Keck T, Knott G, Lee W-CA, Mostany R, Mrsic-Flogel TD, Nedivi E, Portera-Cailliau C, Svoboda K, Trachtenberg JT, Wilbrecht L (2009) Long-term, high-resolution imaging in the mouse neocortex through a chronic cranial window. Nat Protoc 4:1128–1144. doi:10.1038/nprot.2009.89
    OpenUrlCrossRefPubMed
  20. ↵
    Hoover WB, Vertes RP (2007) Anatomical analysis of afferent projections to the medial prefrontal cortex in the rat. Brain Struct Funct 212:149–179. doi:10.1007/s00429-007-0150-4 pmid:17717690
    OpenUrlCrossRefPubMed
  21. ↵
    Ibrahim L, DiazGranados N, Franco-Chaves J, Brutsche N, Henter ID, Kronstein P, Moaddel R, Wainer I, Luckenbaugh DA, Manji HK, Zarate CA (2012) Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study. Neuropsychopharmacology 37:1526–1533. doi:10.1038/npp.2011.338 pmid:22298121
    OpenUrlCrossRefPubMed
  22. ↵
    Ito H, Nagano M, Suzuki H, Murakoshi T (2010) Chronic stress enhances synaptic plasticity due to disinhibition in the anterior cingulate cortex and induces hyper-locomotion in mice. Neuropharmacology 58:746–757. doi:10.1016/j.neuropharm.2009.12.011 pmid:20035774
    OpenUrlCrossRefPubMed
  23. ↵
    Kang HJ, Voleti B, Hajszan T, Rajkowska G, Stockmeier CA, Licznerski P, Lepack A, Majik MS, Jeong LS, Banasr M, Son H, Duman RS (2012) Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nat Med 18:1413–1417. doi:10.1038/nm.2886 pmid:22885997
    OpenUrlCrossRefPubMed
  24. ↵
    Kasai H, Matsuzaki M, Noguchi J, Yasumatsu N, Nakahara H (2003) Structure-stability-function relationships of dendritic spines. Trends Neurosci 26:360–368. doi:10.1016/S0166-2236(03)00162-0 pmid:12850432
    OpenUrlCrossRefPubMed
  25. ↵
    Kassem MS, Lagopoulos J, Stait-Gardner T, Price WS, Chohan TW, Arnold JC, Hatton SN, Bennett MR (2013) Stress-induced grey matter loss determined by MRI is primarily due to loss of dendrites and their synapses. Mol Neurobiol 47:645–661. doi:10.1007/s12035-012-8365-7 pmid:23138690
    OpenUrlCrossRefPubMed
  26. ↵
    Kim Y, Perova Z, Mirrione MM, Pradhan K, Henn FA, Shea S, Osten P, Li B (2016) Whole-brain mapping of neuronal activity in the learned helplessness model of depression. Front Neural Circuits 10:3. doi:10.3389/fncir.2016.00003 pmid:26869888
    OpenUrlCrossRefPubMed
  27. ↵
    Knott GW, Holtmaat A, Wilbrecht L, Welker E, Svoboda K (2006) Spine growth precedes synapse formation in the adult neocortex in vivo. Nat Neurosci 9:1117–1124. doi:10.1038/nn1747 pmid:16892056
    OpenUrlCrossRefPubMed
  28. ↵
    Lai CSW, Franke TF, Gan W-B (2013) Opposite effects of fear conditioning and extinction on dendritic spine remodelling. Nature 482:87–91.
    OpenUrl
  29. ↵
    Li N, Lee B, Liu R-J, Banasr M, Dwyer JM, Iwata M, Li X-Y, Aghajanian G, Duman RS (2010) mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329:959–964. doi:10.1126/science.1190287 pmid:20724638
    OpenUrlAbstract/FREE Full Text
  30. ↵
    Li N, Liu R-J, Dwyer JM, Banasr M, Lee B, Son H, Li X-Y, Aghajanian G, Duman RS (2011) Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry 69:754–761. doi:10.1016/j.biopsych.2010.12.015 pmid:21292242
    OpenUrlCrossRefPubMed
  31. ↵
    Liao Y, Tang J, Corlett PR, Wang X, Yang M, Chen H, Liu T, Chen X, Hao W, Fletcher PC (2011) Reduced dorsal prefrontal gray matter after chronic ketamine use. Biol Psychiatry 69:42–48. doi:10.1016/j.biopsych.2010.08.030 pmid:21035788
    OpenUrlCrossRefPubMed
  32. ↵
    Liston C, Gan W-B (2011) Glucocorticoids are critical regulators of dendritic spine development and plasticity in vivo. Proc Natl Acad Sci U S A 108:16074–16079. doi:10.1073/pnas.1110444108 pmid:21911374
    OpenUrlAbstract/FREE Full Text
  33. ↵
    Liston C, Miller MM, Goldwater DS, Radley JJ, Rocher AB, Hof PR, Morrison JH, McEwen BS (2006) Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set-shifting. J Neurosci 26:7870–7874. doi:10.1523/JNEUROSCI.1184-06.2006 pmid:16870732
    OpenUrlAbstract/FREE Full Text
  34. ↵
    Liu R-J, Fuchikami M, Dwyer JM, Lepack AE, Duman RS, Aghajanian GK (2013) GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine. Neuropsychopharmacology 38:2268–2277. doi:10.1038/npp.2013.128 pmid:23680942
    OpenUrlCrossRefPubMed
  35. ↵
    Liu R-J, Ota KT, Dutheil S, Duman RS, Aghajanian GK (2015) Ketamine strengthens CRF-activated amygdala inputs to basal dendrites in mPFC layer V pyramidal cells in the prelimbic but not infralimbic subregion, a key suppressor of stress responses. Neuropsychopharmacology 40:2066–2075. doi:10.1038/npp.2015.70
    OpenUrlCrossRefPubMed
  36. ↵
    Miyamoto S, Leipzig JN, Lieberman JA, Duncan GE (2000) Effects of ketamine, MK-801, and amphetamine on regional brain 2-deoxyglucose uptake in freely moving mice. Neuropsychopharmacology 22:400–412. doi:10.1016/S0893-133X(99)00127-X pmid:10700659
    OpenUrlCrossRefPubMed
  37. ↵
    Morgan CJA, Muetzelfeldt L, Curran HV (2009) Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls. Addiction 104:77–87. doi:10.1111/j.1360-0443.2008.02394.x pmid:19133891
    OpenUrlCrossRefPubMed
  38. ↵
    Muñoz-Cuevas FJ, Athilingam J, Piscopo D, Wilbrecht L (2013) Cocaine-induced structural plasticity in frontal cortex correlates with conditioned place preference. Nat Neurosci 16:1367–1369. doi:10.1038/nn.3498 pmid:23974707
    OpenUrlCrossRefPubMed
  39. ↵
    Murray CJ, Atkinson C, Bhalla K, Birbeck G, Burstein R, Chou D, Dellavalle R, Danaei G, Ezzati M, Fahimi A, Flaxman D, Foreman, Gabriel S, Gakidou E, Kassebaum N, Khatibzadeh S, Lim S, Lipshultz SE, London S, Lopez, (2013) The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 310:591–608. doi:10.1001/jama.2013.13805
    OpenUrlCrossRefPubMed
  40. ↵
    Oh SW, Harris JA, Ng L, Winslow B, Cain N, Mihalas S, Wang Q, Lau C, Kuan L, Henry AM, Mortrud MT, Ouellette B, Nguyen TN, Sorensen SA, Slaughterbeck CR, Wakeman W, Li Y, Feng D, Ho A, Nicholas E. (2014) A mesoscale connectome of the mouse brain. Nature 508:207–214. doi:10.1038/nature13186 pmid:24695228
    OpenUrlCrossRefPubMed
  41. ↵
    Pologruto TA, Sabatini BL, Svoboda K (2003) ScanImage: flexible software for operating laser scanning microscopes. Biomed Eng Online 2:13. doi:10.1186/1475-925X-2-13 pmid:12801419
    OpenUrlCrossRefPubMed
  42. ↵
    Radley JJ, Rocher AB, Miller M, Janssen WGM, Liston C, Hof PR, McEwen BS, Morrison JH (2006) Repeated stress induces dendritic spine loss in the rat medial prefrontal cortex. Cereb Cortex 16:313–320. doi:10.1093/cercor/bhi104
    OpenUrlAbstract/FREE Full Text
  43. ↵
    Radley JJ, Sisti HM, Hao J, Rocher AB, McCall T, Hof PR, McEwen BS, Morrison JH (2004) Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex. Neuroscience 125:1–6. doi:10.1016/j.neuroscience.2004.01.006 pmid:15051139
    OpenUrlCrossRefPubMed
  44. ↵
    Ruddy RM, Chen Y, Milenkovic M, Ramsey AJ (2015) Differential effects of NMDA receptor antagonism on spine density. Synapse 69:52–56. doi:10.1002/syn.21784 pmid:25220437
    OpenUrlCrossRefPubMed
  45. ↵
    Sanacora G, Schatzberg AF (2015) Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders? Neuropsychopharmacology 40:259–267. doi:10.1038/npp.2014.261
    OpenUrlCrossRefPubMed
  46. ↵
    Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671–675. pmid:22930834
    OpenUrlCrossRefPubMed
  47. ↵
    Schobel SA, Chaudhury NH, Khan UA, Paniagua B, Styner MA, Asllani I, Inbar BP, Corcoran CM, Lieberman JA, Moore H, Small SA (2013) Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver. Neuron 78:81–93. doi:10.1016/j.neuron.2013.02.011
    OpenUrlCrossRefPubMed
  48. ↵
    Shansky RM, Hamo C, Hof PR, McEwen BS, Morrison JH (2009) Stress-induced dendritic remodeling in the prefrontal cortex is circuit specific. Cereb Cortex 19:2479–2484. doi:10.1093/cercor/bhp003 pmid:19193712
    OpenUrlAbstract/FREE Full Text
  49. ↵
    Srivastava DP, Woolfrey KM, Woolfrey K, Jones KA, Shum CY, Lash LL, Swanson GT, Penzes P (2008) Rapid enhancement of two-step wiring plasticity by estrogen and NMDA receptor activity. Proc Natl Acad Sci U S A 105:14650–14655. doi:10.1073/pnas.0801581105 pmid:18801922
    OpenUrlAbstract/FREE Full Text
  50. ↵
    Thévenaz P, Ruttimann UE, Unser M (1998) A pyramid approach to subpixel registration based on intensity. IEEE Trans Image Process 7:27–41. doi:10.1109/83.650848 pmid:18267377
    OpenUrlCrossRefPubMed
  51. ↵
    Trachtenberg JT, Chen BE, Knott GW, Feng G, Sanes JR, Welker E, Svoboda K (2002) Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex. Nature 420:788–794. doi:10.1038/nature01273 pmid:12490942
    OpenUrlCrossRefPubMed
  52. ↵
    Van De Werd HJ, Rajkowska G, Evers P, Uylings HB (2010) Cytoarchitectonic and chemoarchitectonic characterization of the prefrontal cortical areas in the mouse. Brain Struct Funct 214:339–353. doi:10.1007/s00429-010-0247-z pmid:20221886
    OpenUrlCrossRefPubMed
  53. ↵
    Vetere G, Restivo L, Cole CJ, Ross PJ, Ammassari-Teule M, Josselyn SA, Frankland PW (2011) Spine growth in the anterior cingulate cortex is necessary for the consolidation of contextual fear memory. Proc Natl Acad Sci U S A 108:8456–8460. doi:10.1073/pnas.1016275108 pmid:21531906
    OpenUrlAbstract/FREE Full Text
  54. ↵
    Vogt BA, Paxinos G (2014) Cytoarchitecture of mouse and rat cingulate cortex with human homologies. Brain Struct Funct 219:185–192. doi:10.1007/s00429-012-0493-3 pmid:23229151
    OpenUrlCrossRefPubMed
  55. ↵
    Voleti B, Navarria A, Liu R-J, Banasr M, Li N, Terwilliger R, Sanacora G, Eid T, Aghajanian G, Duman RS (2013) Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses. Biol Psychiatry 74:742–749.
    OpenUrlCrossRefPubMed
  56. ↵
    Wellman CL (2001) Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration. J Neurobiol 49:245–253. pmid:11745662
    OpenUrlCrossRefPubMed
  57. ↵
    Xu H-T, Pan F, Yang G, Gan W-B (2007) Choice of cranial window type for in vivo imaging affects dendritic spine turnover in the cortex. Nat Neurosci 10:549–551. doi:10.1038/nn1883 pmid:17417634
    OpenUrlCrossRefPubMed
  58. ↵
    Yang G, Chang PC, Bekker A, Blanck TJJ, Gan W-B (2011) Transient effects of anesthetics on dendritic spines and filopodia in the living mouse cortex. Anesthesiology 115:718–726. doi:10.1097/ALN.0b013e318229a660 pmid:21768874
    OpenUrlCrossRefPubMed

Synthesis

The decision was a result of the Reviewing Editor Christophe Bernard and the peer reviewers coming together and discussing their recommendations until a consensus was reached. A fact-based synthesis statement explaining their decision and outlining what is needed to prepare a revision is listed below. The following reviewers agreed to reveal their identity: Erik Bloss, Juan Nácher

Synthesis of reviews for:

eN-NWR-0133-15 "Longitudinal effects of ketamine on dendritic architecture in vivo in the mouse medial frontal cortex"

Please note that all the reviewers' comments have been integrated to reflect their collective impressions, queries, and suggestions for additional experiments and/or analysis and revisions:

I. Summary

The present manuscript investigates the effects of a single sub anesthetic dose of ketamine on the structural plasticity of superficial dendritic segments of pyramidal neurons in the frontal cortex. The authors study changes in dendritic spine density and dynamics as well as assessing the length of distal apical tuft branches by repeated 2 photon imaging in glass- windowed, transgenically labeled mice. The main finding is that ketamine treatment differentially changes spine dynamics, transiently increasing the rate of spine formation but not spine elimination. Additionally, the authors show some transient remodeling of distal apical tuft dendrites in ketamine but not saline treated mice.

Previous studies have described increases in spine density in pyramidal neurons after ketamine administration. This study extends prior work in that the authors were able to follow the same dendritic fragments over several weeks using 2 photon microscopy and by their findings that the net increase in spine density subsequent to a single dose of ketamine arises from an elevated spine formation rate without alteration in the rate of disappearance of the spines. The authors also find an interesting fast retraction of distal apical tuft branches.

The reviewers agreed that the study was interesting and added to our knowledge of the neurobiological bases of the fast antidepressant actions of NMDA receptor antagonists.

The reviewers also agreed, however, that the findings are less compelling due to two serious potential confounds and the lack of inclusion of more detailed analysis of the branch retraction effect. The first confound is that all of measures are made against a substantial overall loss of spines (as revealed by examination of the saline treated mice). The second confound is the inclusion of (and mixing of data from) both female and male mice. In light of the strong effects that estrogens have on structural plasticity and particularly on spine dynamics, pooling males and females makes the comparison problematic, especially with the low n values employed here. Although the suggested examination of effect by sex might resolve this issue, the phase of the estrous cycle in which the female mice were subjected to analyses should also be considered. Lastly, the authors need to provide some more data on the wholesale retraction of branches. Since the imaging they are doing is relatively straightforward (i.e., in an anesthetized mouse with LV neurons labeled by transgene), the branch retraction effect should be examined in greater detail, and potentially extended with data on axonal structural plasticity (which they should have already).

In summary: the major issues that must be addressed by the authors before the manuscript is suitable for publication in eNeuro are:

  1. Examine the statistics by sex to assess the potential effect of the inclusion of females. (does this explain the particularly high degree of baseline spine retraction, perhaps?)

  2. Include or obtain new data on the spine loss over time in non-injected animals (does the stress of injection per se account for the elevated baseline of retraction?) and

  3. provide some way in which we can understand the high baseline retraction. Whether this means new data or new analysis it certainly should be discussed in more detail.

II Specific Issues: Major

The pooling of male and female mice is problematic given the known fluctuations of spine density in relation to the estrous cycle in female mice, rats, and non-human primates. It would be useful to consider each dataset by sex rather than pooling them together. In fact, given the report by Srivastava et al (PMID:18801922) of two-stage, estrogen+NMDA receptor dependent rewiring, sex differences as a result of ketamine treatment could be interesting. As the n is already low in the ketamine group (n=4), new animals might need to be imaged.

The strongest effect reported in the paper is the spine density decrease over time in the saline treated mice. Compared to the decrease seen by Munoz-Cuevas et al under similar conditions/brain region, the relative spine density change reported here is substantially larger over the same time span (e.g., ∼30% reduction after 11 days in the present work compared to only ∼5% in the Munoz-Cuevas et al report). Previous work from Yang et al (PMID:21768874) would argue against large effects of anesthesia on spines. Although the authors have devoted some text to this finding, can they provide a more realistic rationale as to why spines are being lost at such a high rate in their control preparation? Is there data from non-injected control mice that also show this effect?

A similar fraction of newly formed spines appear to be persistent (at 4 days) between the ketamine and saline groups. Can the authors look at a longer timescale? If not this section of the manuscript should minimized, as it brings little to the table.

The wholesale retraction of dendrites over a small time period is surprising. In particular, the example from Fig. 5 appears to be a thick tuft branch, implying that whole sets of branch families could be remodeled. If this is the case, how do the authors arrive at a 10% change without any knowledge of the dendritic arbor morphology? Are the branches that are lost generally thick, thin, or both? Is it possible to use large field of view imaging to document this effect within the context of a more complete arbor?

III Specific Issues: Minor

  1. The authors presumably have both longitudinal series of cortical and subcortical axons in their acquired datasets. It would be useful to know how bouton dynamics are affected by ketamine, and whether they form dynamic or static subpopulations.

  2. The paragraph on page 16 ("A novel finding...") needs some focus. It was hard to understand exactly what the authors were getting at.

  3. One of the reviewers takes issue with the sentence in the significant statement "Ketamine administration in rodents leads to more synaptic connections in the frontal cortex, measured as higher density of dendritic spines." An increase in synaptic connections does not necessarily mean an increase in dendritic spines, since new synaptic contacts could be made on preexisting spines or in the dendritic shaft. Moreover, an increase in dendritic spines does not necessarily mean an increase in synaptic connections, because the proportion of the new spines might not receive synaptic inputs.

  4. It would be helpful for the reader to have a sentence stating that the strain of mice used in this study only has labeled pyramidal neurons in the frontal cortex. This is important because other similar strains (e.g. Thy1-S mice) also display fluorescent interneurons.

  5. The authors should give more information on the age of the animals when they started the experiments. It is possible that significant differences in the structural plasticity exist between 2 month old and 4 month old animals.

  6. Please include reference for Image J software (http://rsbweb.nih.gov/ij/docs/faqs.html#cite)

  7. It would be interesting to know whether there are differences in the density of the type of spines (stubby, mushroom, filopodia-like...) detected before and after ketamine treatment. Or at least have a sentence in the discussion stating why these type of analysis cannot be performed in this experiment.

  8. The authors should make clearer that the increases in spine density induced by ketamine are detected when comparing the treatment with the effect of saline. This part of the results is a bit confusing, because if one only follows the effect of ketamine, it induces a decrease in this parameter (or virtually no change at 1 day post injection.

  9. I think that the authors should also consider the possibility that the disappearance of some terminal tips of dendrites in layer could be due to the death of certain neuronal populations from which these dendrites arise. They also should cite the work by Nedivi's lab, who found similar dendritic tip remodeling in control cortical interneurons.

  10. In page 16 the authors should provide references for their statement: "Therefore, our results and studies in the field support a structural basis for antidepressant actions that may generalize beyond specific frontal cortical regions or pharmacological agents".

  11. I do not know whether this is possible, because the authors do not give information on whether animals used in the study were perfused at the end. But if this were the case, it would be extremely interesting to investigate what is the main input onto the dendrites/spine under analysis. A simple analysis with VGLUT1 and VGLUT2 receptors would determine the extra/intracortical origin of the projections.

Back to top

In this issue

eneuro: 3 (2)
eNeuro
Vol. 3, Issue 2
March/April 2016
Email
Print
View Full Page PDF
Citation Tools
Respond to this article
Longitudinal Effects of Ketamine on Dendritic Architecture In Vivo in the Mouse Medial Frontal Cortex
Victoria Phoumthipphavong, Florent Barthas, Samantha Hassett, Alex C. Kwan
eNeuro 23 March 2016, 3 (2) ENEURO.0133-15.2016; DOI: 10.1523/ENEURO.0133-15.2016
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Subjects